It has been established that at least some Vf117 + T cells interact with an endogenous superantigen encoded by the murine retrovirus, Mtv-9. To analyze the role of major histocompatibility complex (MHC) dass II molecules in presenting the Mtv-9 encoded superantigen, vSAG-9 to Vf117 + hybridomas, a panel of nine hybridomas was tested for their ability to respond to A20/2J (H-2 a) and LBK (H-2 a) cells which had been transfected with the vSAG-9 gene. Whereas some of the hybridomas recognized vSAG-9 exclusively in the context of H-2 ~, other hybridomas recognized vSAG-9 exclusively in the context of H-2 a or in the context of both H-2 d and H-2 ~. These results suggest that: (a) the class II MHC molecule plays a direct role in the recognition of retroviral superantigen by T cells, rather than serving simply as a platform for presentation; and, (b) it is likely that components of the TCR other than Vfl are involved in the vSAG-9/TCR/class II interaction.
S
uperantigens are defined by their ability to stimulate high frequencies of T cells based predominantly on the V~/ component of the TCR. Bacterial superantigens are toxins produced by certain strains of bacteria, whereas endogenous superantigens are encoded by the 3' LTR of the mouse mammary tumor virus (MMTV) (1) (2) (3) .
T cell recognition of superantigen differs from recognition of conventional antigen in two fundamental ways. First, in contrast to recognition of conventional antigen, which is dependent upon contributions of both the cr and/3 chains of the TCR to the combining site, T cell recognition of superantigen is mediated primarily through the V~ element of the receptor. Second, T cell recognition of superantigen is not classically MHC restricted (1) (2) (3) .
The Mtv-9 encoded superantigen (vSAG-9) interacts with most murine V~5.1 +, VB5.2 +, VB11 +, V~12 +, and V~17 + T cells (4, 5 , and D. L. Woodland and M. A. Blackman, unpublished results). Here, we investigate the role of MHC class II molecules in presenting this endogenous superantigen by examining the response of a panel of Vf117 + T cell hybridomas to Mtv-9 3'LTR transfectants that express vSAG-9 in the context of either H-2 d or H-2 a. It is surprising that hybridomas are shown to distinguish between vSAG-9 presented on different MHC alleles, resulting in a form of MHC restriction. This observation contrasts strongly with the view that T cell responses to retroviral superantigens are independent of the MHC haplotype of the presenting cell, and suggests that non-V~ (DE, JB, Vol, Jo 0 elements of the TCR influence its interaction with the MHC class IIAuperantigen complex.
Materials and Methods
Cells. The V/317+/CD4 + hybridomas were derived from C57/L (H-2 b) T cells as described previously (6) . 11-40 (V/311 +/CD4 +) and KE8 (VBS.1 § +) are T cell hybridomas that react with the Mtv-9 YLTR encoded superantigen, vSAG-9, as detailed elsewhere (4, 5) . The Mtv-9 TLTR, under the control of the human B-actin promoter, was transfeeted into A20 or LBK, as previously described (5, and Lund, et al., manuscript submitted for publication). For this study, we used two A20/2J transfectants, 1H10 and 2C3, and two LBK transfectants, 3G9 and 3H3. A20/2J is derived from BALB/c (I-A a, LE a) mice, and LBK is an in vitroadapted subclone of CH12 that is derived from B10.H-2,H-4bp-Wts (I-A k, I-E k) mice.
Stimulation Assays. 10 s responding hybridomas were cultured either with 10 s B cell tumors (A20/2J, LBK, or Mtv-9 YLTR transfectants), 106 LPS/Ib4-treated spleen cells (7), or immobilized anti-TCR antibody in duplicate 250-/xl cultures. Supematants were tested for II.-2, as previously described (7) . Responses of the hybridomas to staphylococcal enterotoxin D (SED) (Toxin Technology, Sarasota, FL) was determined in the standard stimulation assay by including varying concentrations (10, 1, 0.1, or 0.01 #g/ml) of SED in the presence of A20 or LBK. Antibody inhibition assays were done in the standard stimulation assay by adding purified antibodies (5 gg/ml) to the cultures. The mAbs 10-3.6 (anti-I-AB k) and 14.4.4S (anti-I-E) were generously provided by Dr. John Freed (National Jewish Center for Immunology, Denver, CO) and MKD6 (anti-I-A d) was purchased from Becton Dickinson & Co. (San Jose, CA). All of these antibodies brightly stained the relevant transfectants and parental B cell lines, were capable of inhibiting II.-2 production in appropriate controls, and were not nonspecifically toxic (data not shown).
Results

MHC-restricted
Recognition of vSAG-9 by Vf117 + Hybridomas. We had previously shown that at least some V~17 + hybridomas respond to a superantigen encoded by the retroviral integrant Mtv-9 (vSAG-9) (5). To further investigate the interaction, we screened a panel of 41 V~17 + CD4 + T call hybridomas derived from C57L (H-2 b) mice for reactivity against spleen cells from B10.D2 (H-2 d, Mtv-9*) or B10.BR (H-2 k, Mtv-9 +) mice (6) . Approximately half of the hybridomas (20 of 41) were reactive to B10.D2 and/or B10.BR spleen cells. However, whereas some of the hybridomas responded exclusively to B10.BR spleen cells (13 of 20), other hybridomas responded either exclusively to B10.D2 spleen ceUs (3 of 20), or to spleen cells from both strains (4 of 20; data not shown). This result was surprising, because T cell interaction with other endogenous superantigens had not revealed an MHC-restricted pattern of reactivity.
To eliminate the possibility that these findings were due to the expression of multiple retroviral superantigens by the spleen cells, we analyzed the responses of a selected panel of nine V/~17 +/CD4 + hybridomas to two sets of transfectants expressing vSAG-9 in the context of H-2 a or H-2 a. The response of the hybridomas to the transfectants correlated directly with the MHC-restricted reactivity observed on B10.D2 and B10.BR spleen cells (Table 1) . Thus, some of the hybridomas (2B23-10, -11, and -12) were H-2 a (AkEk)-restricted, in that they responded to vSAG-9 presented on LBK transfectants but not A20/2J transfectants. Conversely, other hybridomas (2B23-40 and -53) were H-2d-(AaE a) restricted, in that they responded to vSAG-9 presented by A20/2J transfectants but not LBK transfectants. The hybridoma, 2B23-18, responded to vSAG-9 presented on both types of transfectants, and this dual reactivity did not segregate in subclones (data not shown). Some of the hybridomas (2B23-8, -26, and -30) failed to respond to any of the transfectants, despite the fact that they secreted I1.-2 in response to immobilized anti-VB17 antibody, and they responded to IE + spleen cells from mice expressing MHC haplotypes other than H-2 k and H-2 d (see Discussion section). The MHC-restricted pattern of vSAG-9 recognition by V~17 + hybridomas cannot be explained by a failure of vSAG-9 to bind to class II molecules on either H-2 a or * Hybridoma responses are presented as IL-2 secretion in U/ml as outlined in Materials and Methods. Responses below the level of detection (<10 U/ml) are indicated by a dash (-). Data represent the mean responses of at hast three independent experiments. Spleen cells were pretreated with LPS and IL-4 to enhance vSAG-9 expression as described by Woodland et al. (7) . s j~ usage by the V~17 + hybridomas was previously determined by Biackman et aL (6) .
H-2 a presenting cells, since both of these haplotypes are good presenters of vSAG-9 to 11-40 (V/$11 +) and KE8 (V~5.1+), hybridomas previously shown to recognize vSAG-9. Thus, the reactivity of VB17 + T cells to endogenous superantigens showed a strong and unexpected influence of the MHC haplotype of the presenting cells.
Class II Presentation of vSAG-9.
To clarify exactly which class II molecules are involved in the presentation of the Mtv-9 superantigen, we tested the ability of various MHC dass II specific antibodies to inhibit the response of VB17 + hybridomas to vSAG-9 presented by H-2 a (1H10) or H-2 a (3G9) transfectants (Table 2) . Those hybridomas that responded to vSAG-9 in the context of H-2 a (11-40, KE8, 2B23-18, -40, and -53) were strongly inhibited by antibodies specific for bE d (14-4-4), but not I-A a (MKD6), indicating that this response is specific for the I-E d molecule. Those hybridomas that responded to vSAG-9 in the context of H-2 a (11-40, KE8, 2B23-10, -11, -12, and -18) showed a surprising restriction pattern. The response of these hybridomas to the H-2 ~ transfectant (3G9) was partially blocked by antibodies specific for either I-A k (10-3.6) or I-E k (14-4-4S), and was completely blocked by combinations of these two antibodies. This pattern was observed consistently in several experiments, and suggests that these hybridomas recognize vSAG-9 presented in association with both I-A k and I-E k. This observation was unexpected since VB17 + T cell responses have been genetically mapped to the I-E molecule. (Table 1) . For example, two hybridomas, 2B23-40 and 2B23-10, both use the same JB2.1 element in the construction of their receptors, despite the fact that they have very different restriction patterns (2B23-40 is I-E a restricted whereas 2B23-10 is I-A k and I-E k restricted). Similarly, hybridomas with identical restriction patterns (2B23-11 and 2B23-12) use very different JB elements (JB1.2 and J/~2.6, respectively).
MHC-restricted Recognition of Bacterial Superantigens.
Because there are functional similarities between superantigens from retroviruses and bacteria, we tested the ability of V/$17 + hybridomas to recognize the bacterial superantigen SED presented on either H-2 d (A20/2J) or H-2 a (LBK) ( Table 3 ). All of the VB17 + hybridomas and 11-40 (V~11 +) responded to SED presented by either A20/2J or LBK, irrespective of their MHC restriction for vSAG-9. The inability of KE8 to recognize SED presented on any MHC haplotype is consistent with the fact that murine VBS.1 + T cells do not recognize this superantigen (1). (H-2 a) were measured in the presence of purified mAbs specific for various MHC class II molecules as described in Materials and Methods. Hybridoma responses are presented as U/ml IL-2 and responses below the level of detection (<10 U/ml) are indicated by a dash ( -). The data are representative examples of three or more independent experiments. * The relevent specificities of each antibody are shown under each antibody's name. * Hybridoma responses are presented as U/ml IL-2 secreted as described in Materials and Methods. Responses below the level of detection (<10 U/ml) are indicated by a dash ( -). The data are a representative example of three independent experiments. No hybridomas responded to SED (10 #g/ml) in the absence of presenting cells. * SED concentrations are in #g/ml.
Discussion
Whereas the requirement for class II in the presentation of superantigens has been established, the molecular details of the interaction are unclear. It has been suggested that both retroviral and bacterial superantigens function by simultaneously binding to the class II molecule of the presenting cell and the VB element of the responding T cell (2) . In this model, the MHC class II molecule acts simply as a generic support for the superantigen, which is consistent with the observations that superantigen stimulation of individual T cells is essentially independent of the class II haplotype of the presenting cells. The general hierarchy of presentation of bacterial and retroviral superantigens to T cells can largely be explained by differences in the affinity of the superantigen for a particular MHC class II allele. However, in several examples, the responses of individual hybridomas and clones to bacterial superantigens have exhibited MHC allelic and isotypic preference that cannot be attributed simply to differences in superantigen binding to MHC (8) (9) (10) . The data presented in this paper extend these observations to show that T cell responses to endogenous superantigens can be MHC restricted.
We have studied the response of V~17 + hybridomas to a series of transfectants which express the MMTV superantigen, vSAG-9, and found, unexpectedly, that there was an MHC haplotype-restricted pattern of recognition. Whereas some hybridomas responded to vSAG-9 presented exclusively by H-2 d transfectants, others responded exclusively to H-2 a transfectants. The MHC-restricted response patterns cannot be simply attributed to (a) differences in levels of class II or vSAG-9 expression on the transfectants; (b) preferential binding of vSAG-9 to class II molecules of one or the other haplotype; or (c), influence of adhesion molecule interactions such as LFA-1/intercellular adhesion molecule-I, since both the H-2 a and H-2 ' transfectants and spleen cells are good presenters of vSAG-9 to appropriate hybridomas.
The simplest explanation for the MHC-restricted interaction between Vf117 + hybridomas and vSAG-9 + transfectants is that there is a direct interaction either between the TCR and the class II molecule itself, or between the TCR and an MHC haplotype-specific dominant peptide presented on class II. This is consistent with the idea that superantigen binding may force the intimate contact of the TCR with class II, as originally proposed by Janeway et al. (2) . It is possible that superantigen recognition is generally not MHC restricted because the interactions between superantigen and class II, or between superantigen and TCR are strong, rendering the forced intimacy between TCR and class II irrelevant. However, if either of the interactions is weak, the contact between non-Vfl elements of the TCR with polymorphic determinants on the class II molecule may either stabilize, or interfere with, the TCR/class II/superantigen complex, resulting in MHCbiased patterns of recognition. Thus, the finding that recognition of vSAG-9, but not SED, by V~17 + hybridomas was MHC restricted, could be explained either by the differences in binding affinity of vSAG-9 and SED with class II, or by the differences in strength of interaction of V317 elements with vSAG-9/class II and with SED/class II.
The finding that the recognition of vSAG-9 by V317 + hybridomas is MHC restricted contrasts starkly with data on the recognition of other endogenous retroviral superantigens by T cells. For example, Mls-1 is presented by several different MHC haplotypes, and most Mls-1 reactive hybridomas and clones respond strongly to Mls-1/H-2 k and Mls-1/H-2 a (3, (11) (12) (13) . In terms of the model described above, a likely possibility is that Mls-1 has a higher affinity for the class II molecule and/or V3 element than vSAG-9, such that an interaction between class II and TCR does not influence the specificity.
The data presented here suggest that the TCK directly interacts with the MHC class II molecule during the recognition of vSAG-9. This interaction likely involves non-VB elements of the TCR since the Vf117 element is encoded by a single member gene family. Although analysis of J3 usage did not reveal an obvious role for J/~ in the MHC restriction of these cells, it is possible that the DB element D3J/~ junction, or ct chain elements control the MHC specificity. Alternatively, the MHC specificity may be determined by combinatorial determinants contributed by both the ot and chains, obscuring a simple correlation with individual elements of the TCR. We have independent data that shows a role for the TCK-oe chain in recognition of Mls-1 by a panel of hybridomas bearing an identical (transgenic) V38.1 + beta chain (14) .
One intriguing result of our studies is that 3 of 3 of the k-restricted hybridomas recognized vSAG-9 in the context of both I-E k and I-A k. This contrasts with genetic analyses that have suggested that only I-E molecules are able to mediate the clonal elimination of V317 + cells (15) . However, it is possible that the original genetic analyses were misleading because only the few strains that express V317 could be examined, and because the stronger deletion on I-E masked the weaker contribution of I-A. Recently, the V317-expressing TCR locus has been backcrossed onto a number of MHCcongenic strains of mice (16) . Analysis of these mice support a role for I-Ak-mediated deletion of V317 + T cells. Thus, in VB17-expressing B10.A(4R)~t mice (I-A ~, I-E-), the percentage of V317 + T cells was reduced, compared with C57/L mice (I-A b, I-E-), and the low frequency of V317 + T cells was dominant in I-Ab/I-A k heterozygous mice, consistent with donal deletion. These data are in agreement with our finding that at least some VB17 § T cells recognize vSAG-9 in the context of I-A k. In support of this, recent data has shown that V317 + T cells interact with additional MMTV encoded superantigens presented in association with I-A molecules (17) .
It is not clear why only some (20 of 41) of the VB17 + T cell hybridomas responded to the vSAG-9 + spleen cells. The lack of response was not due to either low levels of CD4 or TCR, nor to an inability to produce II:2. Moreover, the hybridomas all responded strongly to SED illustrating that they are able to respond to at least some superantigens. One possible explanation, predicted by our model, is that these hybridomas recognize vSAG-9 in the context of MHC molecules other than either H-2 d or H-2 ~. In support of this, the original typing of these hybridomas revealed reactivity to spleen cells of haplotypes not tested here, such as I-Ead3 s (6) .
Taken together, these studies illustrate a central role of class II molecules in presenting retroviral superantigens to T cells. It is likely that each component of the class II/TCRAuperantigen trimolecular complex interacts with the other two components, and that each of these interactions contributes to the overall avidity of the complex. The interactions between TCR and class II may play a major role in T cell recognition of superantigen if the association between class II and superantigen and/or superantigen and TCK is weak.
